{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T05:54:17Z","timestamp":1725861257407},"publisher-location":"Cham","reference-count":25,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319422909"},{"type":"electronic","value":"9783319422916"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-42291-6_37","type":"book-chapter","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T15:10:22Z","timestamp":1468249822000},"page":"377-385","source":"Crossref","is-referenced-by-count":0,"title":["System Prediction of Drug-Drug Interactions Through the Integration of Drug Phenotypic, Therapeutic, Structural, and Genomic Similarities"],"prefix":"10.1007","author":[{"given":"Binglei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(04)01528-1","volume":"5","author":"JH Beijnen","year":"2004","unstructured":"Beijnen, J.H., Schellens, J.H.: Drug interactions in oncology. Lancet Oncol. 5, 489\u2013496 (2004)","journal-title":"Lancet Oncol."},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900026043","volume":"12","author":"CB Nemeroff","year":"2007","unstructured":"Nemeroff, C.B., Preskorn, S.H., Devane, C.L.: Antidepressant drug-drug interactions: clinical relevance and risk management. CNS Spectr. 12, 1\u201313 (2007)","journal-title":"CNS Spectr."},{"key":"37_CR3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","volume":"277","author":"DC Classen","year":"1997","unstructured":"Classen, D.C., Pestotnik, S.L., Evans, R.S., Lloyd, J.F., Burke, J.P.: Adverse drug events in hospitalized patientsExcess length of stay, extra costs, and attributable mortality. JAMA 277, 301\u2013306 (1997)","journal-title":"JAMA"},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.319.7201.7a","volume":"319","author":"S Gottlieb","year":"1999","unstructured":"Gottlieb, S.: Antihistamine drug withdrawn by manufacturer. BMJ. Br. Med. J. 319, 7 (1999)","journal-title":"BMJ. Br. Med. J."},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1001\/jama.283.17.2228-JFD00003-2-1","volume":"283","author":"JE Henney","year":"2000","unstructured":"Henney, J.E.: Withdrawal of troglitazone and cisapride. JAMA, J. Am. Med. Assoc. 283, 2228 (2000)","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/01.CIR.98.9.831","volume":"98","author":"R SoRelle","year":"1998","unstructured":"SoRelle, R.: Withdrawal of Posicor from market. Circulation 98, 831\u2013832 (1998)","journal-title":"Circulation"},{"key":"37_CR7","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","volume":"167","author":"TJ Moore","year":"2007","unstructured":"Moore, T.J., Cohen, M.R., Furberg, C.D.: Serious adverse drug events reported to the food and drug administration, 1998\u20132005. Arch. Intern. Med. 167, 1752\u20131759 (2007)","journal-title":"Arch. Intern. Med."},{"key":"37_CR8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","volume":"31","author":"TD Bjornsson","year":"2003","unstructured":"Bjornsson, T.D., Callaghan, J.T., Einolf, H.J., Fischer, V., Gan, L., et al.: The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metab. Dispos. 31, 815\u2013832 (2003)","journal-title":"Drug Metab. Dispos."},{"key":"37_CR9","unstructured":"http:\/\/www.fda.gov"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2174\/15680266113139990033","volume":"13","author":"F Cheng","year":"2013","unstructured":"Cheng, F., Li, W., Liu, G., Tang, Y.: In silico ADMET prediction: recent advances, current challenges and future trends. Curr. Top. Med. Chem. 13, 1273\u20131289 (2013)","journal-title":"Curr. Top. Med. Chem."},{"key":"37_CR11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2013.01.006","volume":"34","author":"B Percha","year":"2013","unstructured":"Percha, B., Altman, R.B.: Informatics confronts drug\u2013drug interactions. Trends Pharmacol. Sci. 34, 178\u2013184 (2013)","journal-title":"Trends Pharmacol. Sci."},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/msb.2012.26","volume":"8","author":"A Gottlieb","year":"2012","unstructured":"Gottlieb, A., Stein, G.Y., Oron, Y., Ruppin, E., Sharan, R.: INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol. 8, 592 (2012)","journal-title":"Mol. Syst. Biol."},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"e1002998","DOI":"10.1371\/journal.pcbi.1002998","volume":"9","author":"J Huang","year":"2013","unstructured":"Huang, J., Niu, C., Green, C.D., Yang, L., Mei, H., et al.: Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network. PLoS Comput. Biol. 9, e1002998 (2013)","journal-title":"PLoS Comput. Biol."},{"key":"37_CR14","doi-asserted-by":"crossref","first-page":"e61468","DOI":"10.1371\/journal.pone.0061468","volume":"8","author":"A Cami","year":"2013","unstructured":"Cami, A., Manzi, S., Arnold, A., Reis, B.Y.: Pharmacointeraction network models predict unknown drug-drug interactions. PLoS ONE 8, e61468 (2013)","journal-title":"PLoS ONE"},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1136\/amiajnl-2013-002512","volume":"21","author":"F Cheng","year":"2014","unstructured":"Cheng, F., Zhao, Z.: Machine learning-based prediction of drug\u2013drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J. Am. Med. Inform. Assoc. 21, e278\u2013e286 (2014)","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"37_CR16","doi-asserted-by":"publisher","unstructured":"Vilar, S., Harpaz, R, Uriarte, E., Santana, L., Rabadan., R., et al.: Drug\u2013drug interaction through molecular structure similarity analysis. J. Am. Med. Inform. Assoc. (2012). doi: 10.1136\/amiajnl-2012-000935","DOI":"10.1136\/amiajnl-2012-000935"},{"issue":"suppl 1","key":"37_CR17","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart, D.S., Knox, C., Guo, A.C., et al.: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 36(suppl 1), D901\u2013D906 (2008)","journal-title":"Nucl. Acids Res."},{"key":"37_CR18","doi-asserted-by":"crossref","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2011","unstructured":"Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., et al.: DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs. Nucl. Acids Res. 39, D1035\u2013D1041 (2011)","journal-title":"Nucl. Acids Res."},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM OLBoyle","year":"2011","unstructured":"OLBoyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., et al.: Open babel: an open chemical toolbox. J. Cheminf. 3, 33 (2011)","journal-title":"J. Cheminf."},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/ci400010x","volume":"53","author":"F Cheng","year":"2013","unstructured":"Cheng, F., Li, W., Wu, Z., Wang, X., Zhang, C., et al.: Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space. J. Chem. Inf. Model. 53, 753\u2013762 (2013)","journal-title":"J. Chem. Inf. Model."},{"key":"37_CR21","first-page":"S5","volume":"6","author":"K-J Xu","year":"2012","unstructured":"Xu, K.-J., Song, J., Zhao, X.-M.: The drug cocktail network. BMC Syst. Biol. 6, S5 (2012)","journal-title":"BMC Syst. Biol."},{"key":"37_CR22","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","volume":"40","author":"F Zhu","year":"2012","unstructured":"Zhu, F., Shi, Z., Qin, C., Tao, L., Liu, X., et al.: Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucl. Acids Res. 40, D1128\u2013D1136 (2012)","journal-title":"Nucl. Acids Res."},{"key":"37_CR23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","volume":"11","author":"P Willett","year":"2006","unstructured":"Willett, P.: Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11, 1046\u20131053 (2006)","journal-title":"Drug Discov. Today"},{"key":"37_CR24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/jcc.21346","volume":"31","author":"S Vilar","year":"2010","unstructured":"Vilar, S., Karpiak, J., Costanzi, S.: Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: development and application to the \u03b22-adrenergic receptor. J. Comput. Chem. 31, 707\u2013720 (2010)","journal-title":"J. Comput. Chem."},{"key":"37_CR25","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1021\/ja077620l","volume":"130","author":"S Engel","year":"2008","unstructured":"Engel, S., Skoumbourdis, A.P., Childress, J., Neumann, S., Deschamps, J.R., et al.: A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists. J. Am. Chem. Soc. 130, 5115\u20135123 (2008)","journal-title":"J. Am. Chem. Soc."}],"container-title":["Lecture Notes in Computer Science","Intelligent Computing Theories and Application"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-42291-6_37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T05:28:48Z","timestamp":1718688528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-42291-6_37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319422909","9783319422916"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-42291-6_37","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2016]]}}}